(Q36960059)

17 August 2017

1 reference

title

Polymyxin B: similarities to and differences from colistin (polymyxin E). (English)

1 reference

17 August 2017

4

Matthew E Falagas

1 reference

17 August 2017

Andrea Kwa

1

1 reference

17 August 2017

Sofia K Kasiakou

series ordinal

2

1 reference

17 August 2017

Vincent H Tam

series ordinal

3

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Expert Review of Anti-infective Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

811-821

1 reference

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Effects of Large Doses of Colistin Sulphomethate Sodium on Renal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked, c

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Extended spectrum beta-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Use of intravenous polymyxin B during continuous venovenous hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Endotracheal antibiotics for the prevention of tracheobronchial infections in tracheotomized unconscious patients. A comparative study of gentamicin and aminosidin-polymyxin B combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Aerosol Polymyxin and Pneumonia in Seriously Ill Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Endotoxin apheresis for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.5.811

21 January 2018

Identifiers

DOI

10.1586/14787210.5.5.811

1 reference

17 August 2017

1 reference